Clinical trials and pregnancy

Catriona Waitt; Denise Astill; Eleonor Zavala; Ruth A. Karron; Ruth R. Faden; Pamela Stratton; Sarah M. Temkin; Janine A. Clayton

doi:10.1038/s43856-022-00198-1

Communications Medicine (Oct 2022)

Clinical trials and pregnancy

Catriona Waitt,
Denise Astill,
Eleonor Zavala,
Ruth A. Karron,
Ruth R. Faden,
Pamela Stratton,
Sarah M. Temkin,
Janine A. Clayton

Affiliations

Catriona Waitt: University of Liverpool
Denise Astill: Foetal Anti-Convulsant Syndrome New Zealand
Eleonor Zavala: Department of International Health, Bloomberg School of Public Health, Johns Hopkins University
Ruth A. Karron: Department of International Health, Bloomberg School of Public Health, Johns Hopkins University
Ruth R. Faden: Berman Institute for Bioethics, Johns Hopkins University
Pamela Stratton: Office of Research on Women’s Health, National Institutes of Health
Sarah M. Temkin: Office of Research on Women’s Health, National Institutes of Health
Janine A. Clayton: Office of Research on Women’s Health, National Institutes of Health

DOI: https://doi.org/10.1038/s43856-022-00198-1
Journal volume & issue: Vol. 2, no. 1
pp. 1 – 5

Abstract

Read online

Traditionally, there has been a reluctance to involve pregnant people in clinical trials due to complex ethical issues surrounding the risk to unborn babies. However it is crucial that new interventions are safe and effective for all patients and ensuring this can be difficult to achieve in the absence of clinical trials.

Published in Communications Medicine

ISSN: 2730-664X (Online)
Publisher: Nature Portfolio
Country of publisher: United Kingdom
LCC subjects: Medicine
Website: https://www.nature.com/commsmed/

About the journal